Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
162.47 |
144.56 |
142.75 |
137.61 |
116.33 |
Operating profit |
14.50 |
11.46 |
9.59 |
13.61 |
13.13 |
Interest |
7.46 |
5.20 |
4.80 |
5.59 |
5.95 |
Gross profit |
7.90 |
7.20 |
9.84 |
9.46 |
8.06 |
EPS (Rs) |
1.78 |
1.63 |
2.69 |
3.09 |
2.24 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.86 |
0.94 |
5.05 |
1.44 |
0.88 |
Stock adjustment |
-4.44 |
-8.76 |
-2.95 |
-1.90 |
8.09 |
Raw material |
91.76 |
87.83 |
82.83 |
80.11 |
57.70 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
27.38 |
25.00 |
23.77 |
20.69 |
18.84 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
33.27 |
29.03 |
29.51 |
25.10 |
18.57 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
4.14 |
3.79 |
3.83 |
3.41 |
3.30 |
Taxation |
0.97 |
0.87 |
2.02 |
1.46 |
1.60 |
Net profit / loss |
2.80 |
2.54 |
3.99 |
4.58 |
3.17 |
Extra ordinary item |
- |
- |
-0.01 |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.69 |
15.57 |
14.82 |
14.82 |
14.17 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
8.92 |
7.93 |
6.72 |
9.89 |
11.29 |
GPM (%) |
4.84 |
4.95 |
6.65 |
6.80 |
6.88 |
NPM (%) |
1.71 |
1.74 |
2.70 |
3.30 |
2.70 |